Inflammatory Bowel Disease: Diagnosis and TreatmentGary L. Gitnick |
From inside the book
Results 1-3 of 74
Page 194
... therapy ? How often can this occur ? If a patient is in remission , what are the chances of the patient's continuing to do well ? Does it make any difference how the remission was achieved ? Finally , are there any factors capable of ...
... therapy ? How often can this occur ? If a patient is in remission , what are the chances of the patient's continuing to do well ? Does it make any difference how the remission was achieved ? Finally , are there any factors capable of ...
Page 285
... therapy for left - sided ulcerative colitis . Efficacy of 5 - ASA was comparable at all dosages and superior to placebo treatment.43 This study suggests that in acute distal colitis , the intra- rectal dose of 5 - ASA does not seem to ...
... therapy for left - sided ulcerative colitis . Efficacy of 5 - ASA was comparable at all dosages and superior to placebo treatment.43 This study suggests that in acute distal colitis , the intra- rectal dose of 5 - ASA does not seem to ...
Page 316
... therapy in these patients . In general , some variation of the intensive regimen of Truelove and Jewell15 should be used . Usually this therapy can be continued for 7 to 10 days ( rather than 5 ) before it is considered a failure unless ...
... therapy in these patients . In general , some variation of the intensive regimen of Truelove and Jewell15 should be used . Usually this therapy can be continued for 7 to 10 days ( rather than 5 ) before it is considered a failure unless ...
Contents
Approaches to Management | 3 |
Epidemiology | 23 |
Where Have We Been? Where Are We Going? | 29 |
Copyright | |
32 other sections not shown
Other editions - View all
Common terms and phrases
5-aminosalicylic acid abdominal abnormalities abscess acute anal anastomosis ankylosing spondylitis antibiotics antigens arthritis associated azathioprine barium biopsies cancer carcinoma cells chronic clinical colectomy colitis and Crohn's colon colonoscopy complications controlled trial corticosteroids Crohn's colitis Crohn's disease diagnosis diarrhea diet dilatation disease activity disease and ulcerative distal dosage dose drug dysplasia endoscopic enemas epithelial evaluation factors fistulas Gastroenterology genetic histologic hydrocortisone IBD patients ileal ileoanal ileostomy ileum immunosuppressive improved increased inflammation inflammatory bowel disease intestinal intravenous involvement Lancet Lennard-Jones lesions manifestations methotrexate metronidazole mucosa normal obstruction occur oral parenteral nutrition patients with Crohn's patients with ulcerative perianal physician placebo pouch procedure prednisolone prednisone present proctitis prognosis rectal rectum recurrence relapse remission reported resection response risk serum side effects sigmoidoscopic small bowel steroids stool strictures sulfasalazine Surg surgery surgical symptoms therapeutic therapy tion tissue toxic megacolon treated Truelove ulcerative colitis usually